Wells Fargo’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-570
| Closed | -$546 | – | 7397 |
|
|
2023
Q1 | $546 | Hold |
570
| – | – | ﹤0.01% | 6212 |
|
|
2022
Q4 | $281 | Sell |
570
-12,300
| -96% | -$6.06K | ﹤0.01% | 6200 |
|
|
2022
Q3 | $18K | Sell |
12,870
-1,000
| -7% | -$1.4K | ﹤0.01% | 5143 |
|
|
2022
Q2 | $24K | Sell |
13,870
-3,750
| -21% | -$6.49K | ﹤0.01% | 5085 |
|
|
2022
Q1 | $42K | Sell |
17,620
-1,015
| -5% | -$2.42K | ﹤0.01% | 5408 |
|
|
2021
Q4 | $69K | Buy |
18,635
+10,850
| +139% | +$40.2K | ﹤0.01% | 5386 |
|
|
2021
Q3 | $32K | Buy |
7,785
+1,445
| +23% | +$5.94K | ﹤0.01% | 5484 |
|
|
2021
Q2 | $34K | Hold |
6,340
| – | – | ﹤0.01% | 5395 |
|
|
2021
Q1 | $45K | Sell |
6,340
-1,943
| -23% | -$13.8K | ﹤0.01% | 5510 |
|
|
2020
Q4 | $65K | Sell |
8,283
-1,704
| -17% | -$13.4K | ﹤0.01% | 5324 |
|
|
2020
Q3 | $99K | Buy |
9,987
+4,047
| +68% | +$40.1K | ﹤0.01% | 5075 |
|
|
2020
Q2 | $63K | Sell |
5,940
-1,000
| -14% | -$10.6K | ﹤0.01% | 5172 |
|
|
2020
Q1 | $52K | Sell |
6,940
-14,561
| -68% | -$109K | ﹤0.01% | 5103 |
|
|
2019
Q4 | $224K | Buy |
21,501
+12,913
| +150% | +$135K | ﹤0.01% | 4733 |
|
|
2019
Q3 | $87K | Buy |
8,588
+810
| +10% | +$8.21K | ﹤0.01% | 5139 |
|
|
2019
Q2 | $89K | Buy |
7,778
+164
| +2% | +$1.88K | ﹤0.01% | 5112 |
|
|
2019
Q1 | $155K | Buy |
7,614
+1,390
| +22% | +$28.3K | ﹤0.01% | 4869 |
|
|
2018
Q4 | $113K | Buy |
6,224
+179
| +3% | +$3.25K | ﹤0.01% | 4997 |
|
|
2018
Q3 | $160K | Buy |
6,045
+5,545
| +1,109% | +$147K | ﹤0.01% | 4930 |
|
|
2018
Q2 | $15K | Buy |
+500
| New | +$15K | ﹤0.01% | 5546 |
|